Novel 2-Indolinone Derivatives as Promising Agents against Respiratory Syncytial and Yellow Fever Viruses

References

• Graham BS . Advances in antiviral vaccine development. Immunol. Rev. 255(1), 230–242 (2013).
   PubMed Web of Science ®Google Scholar
• De Clercq E , Li G . Approved antiviral drugs over the past 50years. Clin. Microbiol. Rev. 29(3), 695–747 (2016).
   PubMed Web of Science ®Google Scholar
• Ishikawa T , Yamanaka A , Konishi E . A review of successful flavivirus vaccines and the problems with those flaviviruses for which vaccines are not yet available. Vaccine 32(12), 1326–1337 (2014).
   PubMed Web of Science ®Google Scholar
• Davis EH , Barrett ADT . Structure–function of the yellow fever virus envelope protein: analysis of antibody epitopes. Viral Immunol. 33(1), 12–21 (2020).
   PubMed Web of Science ®Google Scholar
• Shearer FM , Longbottom J , Browne AJ et al. Existing and potential infection risk zones of yellow fever worldwide: a modelling analysis. Lancet 6(3), 270–278 (2018).
   Web of Science ®Google Scholar
• WHO . Yellow fever. www.who.int/news-room/fact-sheets/detail/yellow-fever
   Google Scholar
• Monath TP . Yellow fever: an update. Lancet Infect. Dis. 1, 11–20 (2001).
   PubMedGoogle Scholar
• Julander JG , Bantia S , Taubenheim BR et al. BCX4430, a novel nucleoside analog, effectively treats yellow fever in a hamster model. Antimicrob. Agents Chemother. 58, 6607–6614 (2014).
   PubMed Web of Science ®Google Scholar
• Julander JG , Demarest JF , Taylor R et al. An update on the progress of galidesivir (BCX4430), a broad-spectrum antiviral. Antiviral Res. 195, 105180 (2021).
   PubMed Web of Science ®Google Scholar
• Baud D , Gubler DJ , Schaub B , Lanteri MC , Musso D . An update on Zika virus infection. Lancet 390, 2099–2109 (2017).
   PubMed Web of Science ®Google Scholar
• Rather IA , Lone JB , Bajpai VK , Park YH . Zika virus infection during pregnancy and congenital abnormalities. Front. Microbiol. 8, 581 (2017).
   PubMedGoogle Scholar
• Leung C . A lesson learnt from the emergence of Zika virus: what flaviviruses can trigger Guillain–Barré syndrome? J. Med. Virol. 92, 2938–2945 (2020).
   PubMed Web of Science ®Google Scholar
• Kazmi SS , Ali W , Bibi N , Nouroz F . A review on Zika virus outbreak, epidemiology, transmission and infection dynamics. J. Biol. Res. 27, 5 (2020).
   Web of Science ®Google Scholar
• Rezende HR , Romano CM , Claro IM et al. First report of Aedes albopictus infected by dengue and Zika virus in a rural outbreak in Brazil. PLOS ONE 15, e0229847 (2020).
   PubMed Web of Science ®Google Scholar
• Ferdousi T , Cohnstaedt LW , McVey DS , Scoglio CM . Understanding the survival of Zika virus in a vector interconnected sexual contact network. Sci. Rep. 9, 7253 (2019).
   PubMed Web of Science ®Google Scholar
• Blohm GM , Lednicky JA , Márquez M et al. Evidence for mother-to-child transmission of Zika virus through breast milk. Clin. Infect. Dis. 66(7), 1120–1121 (2018).
   PubMed Web of Science ®Google Scholar
• Guo Y , Wang B , Li L et al. Epidemiological and genetic characteristics of respiratory syncytial virus infection in children from Hangzhou after the peak of COVID-19. J. Clin. Virol. 158, 105354 (2023).
   PubMed Web of Science ®Google Scholar
• Mazur NI , Terstappen J , Baral R et al. Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape. Lancet 23, 2–21 (2023).
   Web of Science ®Google Scholar
• Manuel O , Estabrook M . RNA respiratory viral infections in solid organ transplant recipients: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Transpl. Infect. Dis. 33, 1–10 (2019).
   Google Scholar
• Interactions V , Tang W , Li Y et al. Mechanism of cross-resistance to fusion inhibitors conferred by the K394R mutation in respiratory syncytial virus fusion. J. Virol. 95, 1–17 (2021).
   Web of Science ®Google Scholar
• Ahmad A , Eze K , Noulin N et al. EDP-938, a respiratory syncytial virus inhibitor, in a human virus challenge. N. Engl. J. Med. 386, 655–666 (.2022).
   PubMed Web of Science ®Google Scholar
• Devincenzo J , Fathi H , McClure M et al. Treatment with oral ALS-008176, a nucleoside analog, rapidly reduces RSV viral load and clinical disease severity in a healthy volunteer challenge study. Infect. Dis. 1, S66–S69 (2014).
   Google Scholar
• Sourimant J , Lieber CM , Aggarwal M et al. 4′-Fluorouridine is an oral antiviral that blocks respiratory syncytial virus and SARS-CoV-2 replication. Science 375, 161–167 (2021).
   PubMed Web of Science ®Google Scholar
• Jiménez-Somarribas A , Mao S , Yoon J et al. Identification of non-nucleoside inhibitors of the respiratory syncytial virus polymerase complex. J. Med. Chem. 60(6), 2305–2325 (2017).
   PubMed Web of Science ®Google Scholar
• Gomes PA , Pena LJ , Leite ACL . Isatin derivatives and their antiviral properties against arboviruses: a review. Mini Rev. Med. Chem. 19, 56–62 (2023).
   Google Scholar
• Nath R , Pathania S , Grover G et al. Isatin containing heterocycles for different biological activities: analysis of structure activity relationship. J. Mol. Struct. 1222, 128900 (2020).
   Web of Science ®Google Scholar
• Cheke RS , Patil VM , Firke SD et al. Therapeutic outcomes of isatin and its derivatives against multiple diseases: recent developments in drug discovery. Pharmaceuticals 15, 1–34 (2022).
   Web of Science ®Google Scholar
• Chowdhary S , Arora A . A mini review on isatin, an anticancer scaffold with potential activities against neglected tropical diseases (NTDs). Pharmaceuticals 15, 1–35 (2022).
   Web of Science ®Google Scholar
• Elsaman T , Mohamed MS , Eltayib EM et al. Isatin derivatives as broad-spectrum antiviral agents: the current landscape. Med. Chem. Res. 31, 244–273 (2022).
   PubMed Web of Science ®Google Scholar
• Cresawn SG , Condit R . A targeted approach to identification of vaccinia virus postreplicative transcription elongation factors: genetic evidence for a role of the H5R gene in vaccinia transcription. Virology 363(2), 333–341 (2007).
   PubMed Web of Science ®Google Scholar
• Neyts J , De Clercq E . Therapy and short-term prophylaxis of poxvirus infections: historical background and perspectives. Antiviral Res. 57, 25–33 (2003).
   PubMed Web of Science ®Google Scholar
• Pirrung MC , Pansare SV , Das Sarma K et al. Combinatorial optimization of isatin-β-thiosemicarbazones as anti-poxvirus agents. Comb. Chem. 7, 3045–3050 (2005).
   Google Scholar
• Kang I , Wang L , Hsu T et al. Isatin-β-thiosemicarbazones as potent herpes simplex virus inhibitors. Bioorg. Med. Chem. Lett. 21(7), 1948–1952 (2011).
   PubMed Web of Science ®Google Scholar
• Sevinçli ZŞ , Duran GN , Özbil M , Karalı N . Synthesis, molecular modeling and antiviral activity of novel 5-fluoro-1H-indole-2,3-dione 3-thiosemicarbazones. Bioorg. Chem. 104, 104202 (2020).
   PubMed Web of Science ®Google Scholar
• Teitz Y , Ronen D , Vansover A . Inhibition of human immunodeficiency virus by N-methylisatin-β/4′:4′-diethylthiosemicarbazone and N-allylisatin-β-4′:4′-diallythiosemicarbazone. Antiviral Res. 24, 305–314 (1994).
   PubMed Web of Science ®Google Scholar
• Bal TR , Anand B , Yogeeswari P et al. Synthesis and evaluation of anti-HIV activity of isatin β-thiosemicarbazone derivatives. Bioorg. Med. Chem. Lett. 15, 4451–4455 (2005).
   PubMed Web of Science ®Google Scholar
• Selvam P , Chandramohan M , De Clercq E , Witvrouw M , Pannecouque C . Synthesis and anti-HIV activity of 4-[(1,2-dihydro-2-oxo-3H-indol-3-ylidene) amino]-N(4,6-dimethyl-2-pyrimidinyl)-benzene sulfonamide and its derivatives. Eur. J. Pharm. Sci. 14(4), 313–316 (2001).
   PubMed Web of Science ®Google Scholar
• Sriram D , Ratan Bal T , Yogeeswari P . Aminopyimidinimo isatin analogues: design of novel non-nucleoside HIV-1 reverse transcriptase inhibitors with broadspectrum chemotherapeutic properties. J. Pharm. Pharm. Sci. 8, 565–577 (2005).
   PubMed Web of Science ®Google Scholar
• Sriram D , Yogeeswari P , Gopal G . Synthesis, anti-HIV and antitubercular activities of lamivudine prodrugs. Eur. J. Med. Chem. 40(12), 1373–1376 (2005).
   PubMed Web of Science ®Google Scholar
• Terzioǧlu N , Karali N , Gürsoy A et al. Synthesis and primary antiviral activity evaluation of 3-hydrazono-5-nitro-2-indolinone derivatives. Arkivoc 1, 109–118 (2006).
   Google Scholar
• Abbas SY , Farag AA , Ammar YA et al. Synthesis, characterization, and antiviral activity of novel fluorinated isatin derivatives. Monatsh. Chem. 144, 1725–1733 (2013).
   PubMed Web of Science ®Google Scholar
• Yu K , Zhang Y , Civiello RL et al. Respiratory syncytial virus inhibitors. Part 2: benzimidazol-2-one derivatives. Bioorg. Med. Chem. Lett. 14(5), 1133–1137 (2004).
   Google Scholar
• Wang XA , Cianci CW , Yu K et al. Respiratory syncytial virus fusion inhibitors. Part 5: optimization of benzimidazole substitution patterns towards derivatives with improved activity. Bioorg. Med. Chem. Lett. 17, 4592–4598 (2007).
   PubMed Web of Science ®Google Scholar
• El-Masry RM , Al-Karmalawy AA , Alnajjar R et al. Newly synthesized series of oxoindole–oxadiazole conjugates as potential anti-SARS-CoV-2 agents: in silico and in vitro studies. New J. Chem. 46, 5078–5090 (2022).
   Web of Science ®Google Scholar
• Fikatas A , Vervaeke P , Meyen E et al. A novel series of indole alkaloid derivatives inhibit dengue and Zika virus infection by interference with the viral replication complex. Antimicrob. Agents Chemother. 65(8), e02349–20 (2021).
   PubMed Web of Science ®Google Scholar
• Monsalve-Escudero LM , Loaiza-Cano V , Pájaro-González Y et al. Indole alkaloids inhibit Zika and chikungunya virus infection in different cell lines. BMC Complem. Med. Ther. 21, 216 (2021).
   PubMedGoogle Scholar
• Nie S , Zhao J , Wu X et al. Synthesis, structure–activity relationship and antiviral activity of indole-containing inhibitors of flavivirus NS2B-NS3 protease. Eur. J. Med. Chem. 225, 113767 (2021).
   Web of Science ®Google Scholar
• Demir-Yazıcı K , Apaydin ÇB , Soylu-Eter Ö et al. Synthesis, molecular modeling and cholinesterase inhibitory effects of 2-indolinone-based hydrazinecarbothioamides. Future Med. Chem. 13, 2133–2151 (2021).
   PubMed Web of Science ®Google Scholar
• Apaydın ÇB , Soylu-Eter Ö , Eraslan-Elma P et al. Synthesis and molecular modeling studies of 1-benzyl-2-indolinones as selective AChE inhibitors. Future Med. Chem. 14(23), 1705–1723 (2022).
   PubMed Web of Science ®Google Scholar
• Vrijens P , Noppen S , Boogaerts T et al. Influenza virus entry via the GM3 ganglioside-mediated platelet-derived growth factor receptor B signalling pathway. J. Gen. Virol. 100(4), 583–601 (2019).
   PubMed Web of Science ®Google Scholar